Delving into the Latest Updates on Sound Biopharmaceuticals Ltd. with Synapse

Overview

Tags

Neoplasms

Hemic and Lymphatic Diseases

Immune System Diseases

Monoclonal antibody

Bispecific antibody

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	6
Hemic and Lymphatic Diseases	2
Immune System Diseases	2
Nervous System Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Monoclonal antibody	4
Bispecific antibody	3

Top 5 Target	Count

CD38(Lymphocyte differentiation antigen CD38)	2
4-1BB x TAA	1
4-1BBL x 5T4	1
4-1BB(Tumor necrosis factor receptor superfamily member 9)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

2

Preclinical

IND Application

1

3

Phase 1

Other

7

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

FTL-008.16 ( 4-1BBL x 5T4 )	Advanced Malignant Solid Neoplasm More	Phase 1
FTL-001 ( 4-1BB )	Advanced Malignant Solid Neoplasm More	Phase 1
FTL004 ( CD38 )	Multiple Myeloma More	Phase 1
FTL008.17 ( 4-1BB x TAA )	Neoplasms More	Preclinical
FTL018	Neoplasms More	Preclinical